Biogen $BIIB Pre-market 291.00 +22.65 (8.44%)
After Biogen and Eisai Co. Ltd complete submission of Biologics License Application to the FDA for the approval of aducanumab #Biotech $SPX #NDX Update https://t.co/OQ0YSzJuaP